Serum miR-1290 as a Marker of Pancreatic Cancer—Response
Year: 2013
Type: article
Abstract: The authors thank Frampton and colleagues for their interest in our study. They commented on our use of miR-16, stating that because studies have reported that red blood cells are a major source of miR-16 and serum levels are elevated in hemolyzed blood samples, there is debate about whether it is a
Source: Clinical Cancer Research
Institution: Johns Hopkins University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2134318948